Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Silverman

Showing results (681-690 of 816) with videos related to

Pageof 82
Sort By:
Pediatric Blood & Cancer|August 13, 2009
Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemiaLynda M Vrooman, Jeffrey G Supko, Donna S Neuberg, et al.
Blood Advances|October 25, 2024
Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children's Oncology Group AALL1931 studyLuke Maese, Mignon L Loh, Mi Rim Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2016
Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary TherapyAjay Vora, Anita Andreano, Ching-Hon Pui, et al.
Research in Developmental Disabilities|April 16, 2014
A review of atomoxetine effects in young people with developmental disabilitiesMichael G Aman, Tristram Smith, L Eugene Arnold, et al.
Blood Advances|July 11, 2023
Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trialsShai Shimony, Yael Flamand, Yannis K Valtis, et al.
The Pharmacogenomics Journal|December 14, 2016
Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemiaM Krajinovic, J Elbared, S Drouin, et al.
Pharmacogenomics|August 2, 2014
Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemiaFrancesco Ceppi, Chloé Langlois-Pelletier, Vincent Gagné, et al.
Plos One|January 22, 2015
The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemiaXiqun Chen, Pauline Wales, Luisa Quinti, et al.
Clinical Pharmacology and Therapeutics|June 22, 2026
Genetic Determinants of Treatment-Related Bone Toxicity in Pediatric Acute Lymphoblastic LeukemiaRachid Abaji, Vincent Gagné, Émilie Espagne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic LeukemiaYana Pikman, Gabriela Alexe, Giovanni Roti, et al.
Pageof 82

Showing results (681-690 of 816) with videos related to

Sort By:
Pageof 82
Pediatric Blood & Cancer|August 13, 2009
Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemiaLynda M Vrooman, Jeffrey G Supko, Donna S Neuberg, et al.
Blood Advances|October 25, 2024
Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children's Oncology Group AALL1931 studyLuke Maese, Mignon L Loh, Mi Rim Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2016
Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary TherapyAjay Vora, Anita Andreano, Ching-Hon Pui, et al.
Research in Developmental Disabilities|April 16, 2014
A review of atomoxetine effects in young people with developmental disabilitiesMichael G Aman, Tristram Smith, L Eugene Arnold, et al.
Blood Advances|July 11, 2023
Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trialsShai Shimony, Yael Flamand, Yannis K Valtis, et al.
The Pharmacogenomics Journal|December 14, 2016
Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemiaM Krajinovic, J Elbared, S Drouin, et al.
Pharmacogenomics|August 2, 2014
Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemiaFrancesco Ceppi, Chloé Langlois-Pelletier, Vincent Gagné, et al.
Plos One|January 22, 2015
The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemiaXiqun Chen, Pauline Wales, Luisa Quinti, et al.
Clinical Pharmacology and Therapeutics|June 22, 2026
Genetic Determinants of Treatment-Related Bone Toxicity in Pediatric Acute Lymphoblastic LeukemiaRachid Abaji, Vincent Gagné, Émilie Espagne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic LeukemiaYana Pikman, Gabriela Alexe, Giovanni Roti, et al.
Pageof 82